Jacob Schoeff
Medical · Smyrna, GANPI 1942824990
Payments from drug & device makers
Across 267 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$792
- AstraZeneca$635
- Lilly USA, LLC$382
- Pfizer$284
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$244
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,364100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 60 | $1,055 |
| AbbVie | 30 | $792 |
| AstraZeneca | 32 | $635 |
| Lilly USA, LLC | 22 | $382 |
| Pfizer | 13 | $284 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $244 |
| Bayer | 11 | $231 |
| Idorsia Pharmaceuticals US Inc | 10 | $207 |
| Sanofi-aventis U.S. LLC | 8 | $194 |
| Shield Therapeutics Inc | 7 | $160 |
| Axsome Therapeutics, Inc. | 6 | $159 |
| GSK | 7 | $113 |
| Novartis | 5 | $103 |
| Exact Sciences | 5 | $98 |
| Dexcom, Inc. | 6 | $93 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $71 |
| Xeris Pharmaceuticals, Inc. | 3 | $71 |
| Amgen | 4 | $66 |
| Merck | 3 | $61 |
| Eisai Inc. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Boehringer Ingelheim | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $22 |
| Edwards Lifesciences | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Neuronetics, Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$5,364 in reported general payments places this provider in the 85th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 41 | $49,757 |
| OzempicSemaglutide | 33 | $44,067 |
| MounjaroTirzepatide | 20 | $39,942 |
| FarxigaDapagliflozin Propanediol | 31 | $31,704 |
| RybelsusSemaglutide | 16 | $22,090 |
| EliquisApixaban | 13 | $21,503 |
| TrulicityDulaglutide | 12 | $18,043 |
| KerendiaFinerenone | 16 | $15,498 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $9,321 |
| Gabapentin | 65 | $1,318 |
| Atorvastatin Calcium | 106 | $1,144 |
| Rosuvastatin Calcium | 125 | $1,116 |
| Pregabalin | 23 | $1,085 |
| Levothyroxine Sodium | 110 | $1,083 |
| Losartan Potassium | 111 | $1,053 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,055 | $66,15749 claims |
| Lilly USA, LLCMounjaro, Trulicity | $382 | $57,98432 claims |
| Boehringer IngelheimJardiance | $34 | $49,75741 claims |
| AstraZenecaFarxiga | $635 | $31,70431 claims |
| PfizerEliquis | $284 | $21,50313 claims |
| BayerKerendia | $231 | $15,49816 claims |
| AbbVieSynthroid | $792 | $57113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 950 medical providers in Georgia.
Other medical in Smyrna
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
- Sally BrumbillLithia Springs$110K
- Danna Dennis-CalderAtlanta$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.